CHRISTINA JOHANSEN: Open Payments
NPI 1629550058 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,511 in 69 payments from 31 companies in 2025. Trend: 2023 $1,104 · 2024 $1,289 · 2025 $1,511
Food & beverage: $1,511
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $142 |
| Novartis Pharmaceuticals Corporation | 6 | $129 |
| Gilead Sciences, Inc. | 5 | $114 |
| Astellas Pharma US Inc | 5 | $102 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $75 |
| ABBVIE INC. | 3 | $73 |
| ARRAY BIOPHARMA INC | 3 | $69 |
| Karyopharm Therapeutics Inc. | 4 | $65 |
| E.R. Squibb & Sons, L.L.C. | 3 | $62 |
| Fennec Pharmaceuticals, Inc. | 2 | $49 |
Products named: Trodelvy, Vyloy, KISQALI, XPOVIO, IMFINZI, OPDIVO, FRUZAQLA, EPKINLY.
Industry payments across FL — which companies pay providers there.
